Artykuły w czasopismach na temat „Lung and breast/ovarian cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Lung and breast/ovarian cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero i Javier Cortes. "Molecular identification of basal-like breast cancer through genomic analyses across five cancer types." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Pełny tekst źródłaAchariyapota, Vuthinun, Tuenjai Chuangsuwanich i Mongkol Benjapibal. "Inflammatory Breast Cancer from Metastatic Ovarian Cancer". Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Pełny tekst źródłaR., Abhirup H., Priyanka Kenchetty i Aishwarya K. Chidananda. "Breast ovarian cancer syndrome". International Surgery Journal 8, nr 8 (28.07.2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Pełny tekst źródłaAbu-Tineh, Mohammad, Hind Elmalik i Mohamed A. Yassin. "Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report". Case Reports in Oncology 13, nr 2 (28.07.2020): 867–74. http://dx.doi.org/10.1159/000508358.
Pełny tekst źródłaBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu i Iulian Brezean. "Breast metastases from ovarian cancer". Romanian Medical Journal 69, S4 (20.06.2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Pełny tekst źródłaArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law i Gillian E. Hanley. "Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada". International Journal of Gynecologic Cancer 29, nr 3 (21.12.2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Pełny tekst źródłaHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni i in. "Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Pełny tekst źródłaTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue i Ginette Serrero. "Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies". Cancer Research 83, nr 8_Supplement (14.04.2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Pełny tekst źródłaRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick i Nshimirimana Eric. "Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report". International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, nr 10 (23.09.2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Pełny tekst źródłaYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks i in. "Development of a Multimarker Assay for Early Detection of Ovarian Cancer". Journal of Clinical Oncology 28, nr 13 (1.05.2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Pełny tekst źródłaTkaczuk, Katherine, Paula Rosenblatt, Ranee Mehra, Katherine Scilla, Nancy Tait, Binbin Yue i Ginette Serrero. "Abstract PO5-18-06: On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy". Cancer Research 84, nr 9_Supplement (2.05.2024): PO5–18–06—PO5–18–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-18-06.
Pełny tekst źródłaCovic, Lidija, i Athan Kuliopulos. "Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach". International Journal of Molecular Sciences 19, nr 8 (31.07.2018): 2237. http://dx.doi.org/10.3390/ijms19082237.
Pełny tekst źródłaO'Shannessy, Daniel J., Darren W. Davis, Kenna Anderes i Elizabeth B. Somers. "Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha". Biomarker Insights 11 (styczeń 2016): BMI.S35075. http://dx.doi.org/10.4137/bmi.s35075.
Pełny tekst źródłaSaad, Hebatallah M., Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh i in. "The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity". Diagnostics 12, nr 12 (29.11.2022): 2985. http://dx.doi.org/10.3390/diagnostics12122985.
Pełny tekst źródłaBodogai, Monica, Purevdorj Olkhanud, Yrina Rochman, Enkhzol Malchinkhuu, Katarzyna Wejksza, Ronald Gress, Charles Hesdorffer, Warren Leonard i Arya Biragyn. "Thymic stromal lymphopoietin mediates breast cancer progression and metastasis (48.9)". Journal of Immunology 186, nr 1_Supplement (1.04.2011): 48.9. http://dx.doi.org/10.4049/jimmunol.186.supp.48.9.
Pełny tekst źródłaKarim, Md Adnan, Abdus Samad, Utpal Kumar Adhikari, Md Ashraful Kader, Md Masnoon Kabir, Md Aminul Islam i Md Nazmul Hasan. "A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches". Biomedicines 8, nr 2 (21.01.2020): 19. http://dx.doi.org/10.3390/biomedicines8020019.
Pełny tekst źródłaPinheiro, Céline, Rui M. Reis, Sara Ricardo, Adhemar Longatto-Filho, Fernando Schmitt i Fátima Baltazar. "Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44". Journal of Biomedicine and Biotechnology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/427694.
Pełny tekst źródłaWeiss, Jessica M., Muhammad Danyal Ahsan, Emily M. Webster, Sarah R. Levi, Murtaza Qazi, Benedict Harvey, Evelyn Cantillo i in. "Hereditary breast and ovarian cancer syndrome: A misnomer?" Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 10594. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10594.
Pełny tekst źródłaArason, Agnarsson, Johannesdottir, Johannsson, Hilmarsdottir, Reynisdottir i Barkardottir. "The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability". Genes 10, nr 11 (1.11.2019): 882. http://dx.doi.org/10.3390/genes10110882.
Pełny tekst źródłaErickson-Miller, Connie L., Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin i Conrad Messam. "Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines." Blood 114, nr 22 (20.11.2009): 2409. http://dx.doi.org/10.1182/blood.v114.22.2409.2409.
Pełny tekst źródłaBenti, Senyi, Purushottam B. Tiwari, Dustin W. Goodlett, Leily Daneshian, Grant B. Kern, Mark D. Smith, Aykut Uren, Maksymilian Chruszcz, Linda S. Shimizu i Geeta Upadhyay. "Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death". Cancers 12, nr 2 (22.02.2020): 509. http://dx.doi.org/10.3390/cancers12020509.
Pełny tekst źródłaCalaf, Gloria M., Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo i Tammy C. Bleak. "Muscarinic Receptors Associated with Cancer". Cancers 14, nr 9 (7.05.2022): 2322. http://dx.doi.org/10.3390/cancers14092322.
Pełny tekst źródłaFerreira, Thamara, Thais Ferreira Bomfim-Palma, Isabelle Joyce de Lima Silva-Fernandes, Gabriela Espirito Santo Felix, Inacelli Queiroz De Souza Caires, Leandro Apolinário Silva, Luciana Garcia Landeiro i in. "PALB2 mutations in Brazilian patients from North-Northeast regions." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e13670-e13670. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13670.
Pełny tekst źródłaDUPONT, J., C. AGHAJANIAN, P. SABBATINI i D. R. SPRIGGS. "New agents for the treatment of ovarian cancer: the next generation". International Journal of Gynecologic Cancer 15, Suppl 3 (listopad 2005): 252–57. http://dx.doi.org/10.1136/ijgc-00009577-200511001-00012.
Pełny tekst źródłaMuggia, Franco M. "Significant developments in ovarian, breast and lung cancer therapy". Inpharma Weekly &NA;, nr 994 (lipiec 1995): 3–5. http://dx.doi.org/10.2165/00128413-199509940-00002.
Pełny tekst źródłaBrown, Geoffrey. "Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer". International Journal of Molecular Sciences 24, nr 15 (28.07.2023): 12089. http://dx.doi.org/10.3390/ijms241512089.
Pełny tekst źródłaCole, Alexander P., Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz i in. "Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers". Journal of the National Comprehensive Cancer Network 17, nr 9 (wrzesień 2019): 1049–58. http://dx.doi.org/10.6004/jnccn.2019.7296.
Pełny tekst źródłaSolomon, Benjamin Maurice, Kari G. Rabe, Susan L. Slager, Jerry D. Brewer, James R. Cerhan i Tait D. Shanafelt. "Overall and cancer-specific survival of breast, colon, and lung cancer in patients with and without chronic lymphocytic leukemia: A SEER population-based study of over 1 million patients." Journal of Clinical Oncology 30, nr 15_suppl (20.05.2012): 6571. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6571.
Pełny tekst źródłaLawler, Thomas, i Shaneda Warren Andersen. "Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies". Nutrients 15, nr 2 (13.01.2023): 422. http://dx.doi.org/10.3390/nu15020422.
Pełny tekst źródłaGuo, Maoni, i San Ming Wang. "The BRCAness Landscape of Cancer". Cells 11, nr 23 (1.12.2022): 3877. http://dx.doi.org/10.3390/cells11233877.
Pełny tekst źródłaCheng, En, Donghoon Lee, Rulla M. Tamimi, Susan Hankinson, Walter C. Willett, Edward L. Giovannucci, Heather Eliassen i in. "Long-term cancer survival in cohorts of U.S. health professionals." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): 12075. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12075.
Pełny tekst źródłaTourassi, Georgia, Hong-Jun Yoon, Songhua Xu i Xuesong Han. "The utility of web mining for epidemiological research: studying the association between parity and cancer risk". Journal of the American Medical Informatics Association 23, nr 3 (27.11.2015): 588–95. http://dx.doi.org/10.1093/jamia/ocv141.
Pełny tekst źródłaLuo, Huiyan, Pansong Li, Wei Wei, Yong-Bin Lin, Hong Yang, Han Yang, Kong-Jia Luo i in. "High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study." Journal of Clinical Oncology 42, nr 16_suppl (1.06.2024): 3043. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3043.
Pełny tekst źródłaOlea-Flores, Monserrat, Juan C. Juárez-Cruz, Miriam D. Zuñiga-Eulogio, Erika Acosta, Eduardo García-Rodríguez, Ana E. Zacapala-Gomez, Miguel A. Mendoza-Catalán, Julio Ortiz-Ortiz, Carlos Ortuño-Pineda i Napoleón Navarro-Tito. "New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin". Biomolecules 10, nr 12 (15.12.2020): 1676. http://dx.doi.org/10.3390/biom10121676.
Pełny tekst źródłaBacalbasa, N., A. Traistaru i I. Balescu. "OVARIAN METASTATIC TUMORS – A LITERATURE REVIEW". Romanian Medical Journal 62, nr 2 (30.06.2015): 115–18. http://dx.doi.org/10.37897/rmj.2015.2.6.
Pełny tekst źródłaAdeboyeje, Gboyega, Eleanor O. Caplan, Yihua Xu, Monica Chase, Sheetal Sheth, Brandon T. Suehs i Nicole Myer. "Abstract 4111: Trends in the use of broad genomic sequencing-directed therapy among Medicare patients with newly diagnosed advanced cancer in the United States from 2018-2020: A retrospective analysis from the SEQUENCE study". Cancer Research 82, nr 12_Supplement (15.06.2022): 4111. http://dx.doi.org/10.1158/1538-7445.am2022-4111.
Pełny tekst źródłaYap, Timothy A., Arya Ashok, Jessica Stoll, Anna Ewa Schwarzbach, Kimberly L. Blackwell, Tianhong Li, Hyunseok Kang, Judy Ellen Garber i Funda Meric-Bernstam. "Rate of incidental germline findings detected by tumor-normal matched sequencing in cancer types lacking hereditary cancer testing guidelines." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 10582. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10582.
Pełny tekst źródłaVlasenkova, Ramilia, Alsina Nurgalieva, Natalia Akberova, Mikhail Bogdanov i Ramziya Kiyamova. "Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases". Biomolecules 11, nr 12 (14.12.2021): 1878. http://dx.doi.org/10.3390/biom11121878.
Pełny tekst źródłaAtta, Ihab Shafek, i Fahd Nasser AlQahtani. "Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence". Case Reports in Medicine 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/2928084.
Pełny tekst źródłaHeeke, Arielle Lutterman, Tabari Baker, Filipa Lynce, Michael J. Pishvaian i Claudine Isaacs. "Prevalence of homologous recombination deficiency among all tumor types." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): 1502. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1502.
Pełny tekst źródłaBel’skaya, Lyudmila V., Elena A. Sarf, Alexandra I. Loginova, Dmitry M. Vyushkov i En Djun Choi. "Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study". Current Issues in Molecular Biology 45, nr 6 (10.06.2023): 5084–98. http://dx.doi.org/10.3390/cimb45060323.
Pełny tekst źródłaChen, Lifeng, Binbing Ling, Jane Alcorn i Jian Yang. "Quantitative Analysis of the Expression of Human N-myristoyltransferase 1 (hNMT-1) in Cancers". Open Biomarkers Journal 2, nr 1 (13.03.2009): 6–10. http://dx.doi.org/10.2174/1875318300902010006.
Pełny tekst źródłaCuriel, Tyler, Suzanne Thibodeaux, Shawna Wall, Sri Lakshmi Pandeswara, Benjamin Daniel, Justin Drerup, Kruthi Murthy, Ilona Kryczek, Weiping Zou i Brian Barnett. "Denileukin diftitox depletes regulatory T cells without clinical benefit in advanced stage epithelial ovarian carcinoma (VAC3P.945)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 73.7. http://dx.doi.org/10.4049/jimmunol.192.supp.73.7.
Pełny tekst źródłaDetopoulou, Paraskevi, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos i Andrea Paola Rojas Gil. "Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer". Current Oncology 30, nr 3 (14.03.2023): 3391–420. http://dx.doi.org/10.3390/curroncol30030258.
Pełny tekst źródłaChoi, Eunji, Justin Lee, Julie T. Wu, Heather A. Wakelee, Lidia Schapira, Allison W. Kurian i Summer S. Han. "Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors". Cancer Prevention Research 16, nr 1_Supplement (1.01.2023): P055. http://dx.doi.org/10.1158/1940-6215.precprev22-p055.
Pełny tekst źródłaSah, Sunil Kumar, Naval Kishor Yadav, Roshan Kurmi, Ramanuj Rauniyar, Krishan Das Manandhar i Birendra Prasad Gupta. "Pattern of Cancer in Nepal from 2003 to 2011". Nepal Journal of Biotechnology 4, nr 1 (31.12.2016): 54–60. http://dx.doi.org/10.3126/njb.v4i1.16348.
Pełny tekst źródłaLindsay, Colin R., Emily C. Shaw, Fiona Blackhall, Kevin G. Blyth, James D. Brenton, Anshuman Chaturvedi, Noel Clarke i in. "Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme". ESMO Open 3, nr 6 (wrzesień 2018): e000408. http://dx.doi.org/10.1136/esmoopen-2018-000408.
Pełny tekst źródłaSun, Ming-Yang, Chia-Lun Chang, Chang-Yun Lu, Szu-Yuan Wu i Jia-Qiang Zhang. "Sarcopenia as an Independent Risk Factor for Specific Cancers: A Propensity Score-Matched Asian Population-Based Cohort Study". Nutrients 14, nr 9 (2.05.2022): 1910. http://dx.doi.org/10.3390/nu14091910.
Pełny tekst źródłaMetzen, Marlon, Michael Bruns, Wolfgang Deppert i Udo Schumacher. "Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models". International Journal of Molecular Sciences 22, nr 8 (19.04.2021): 4213. http://dx.doi.org/10.3390/ijms22084213.
Pełny tekst źródłaKawashiri, Takehiro, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue i Takao Shimazoe. "Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)". Journal of Pharmacy & Pharmaceutical Sciences 24 (11.10.2021): 499–508. http://dx.doi.org/10.18433/jpps31862.
Pełny tekst źródła